We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
PHARMACOR SITAGLIPTIN/METFORMIN (Pharmacor Pty Ltd)
Product name
PHARMACOR SITAGLIPTIN/METFORMIN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
124 (255 working days)
Active ingredients
metformin hydrochloride, sitagliptin hydrochloride monohydrate
Registration type
New generic medicine
Indication
PHARMACOR SITAGLIPTIN/METFORMIN (sitagliptin hydrochloride monohydrate and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.